AACU on updates to Cigna Modifier 25 policy

Press Release

As you may know, Cigna recently updated its Modifier 25 – Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Same Day of the Procedure or Other Service policy to require submission of office notes with all claims including evaluation and management (E/M) Current Procedural Terminology (CPT®) codes 99212, 99213, 99214, and 99215 and modifier 25 when a minor procedure is billed.

The AACU has strong concerns regarding this policy and its associated administrative waste and burdens.

The AACU has strong concerns regarding this policy and its associated administrative waste and burdens.

Cigna will deny payment for E/M services reported with modifier 25 if records documenting a significant and separately identifiable service are not submitted with the claim beginning 5/25/23 or 6/11/23, depending on state.

The AACU has strong concerns regarding this policy and its associated administrative waste and burdens and is working with the AMA federation to request that Cigna rescind its modifier 25 policy and partner with medical organizations on an educational initiative on correct use of the modifier. If you have questions, please contact Kristin Jimison.

Related Videos
Group of doctors reading a document | Image Credit: © Flamingo Images - stock.adobe.com
Colin P. West, MD, PhD, answers a question during a Zoom video interview
Doctor holding hands with patient | Image Credit: © C Davids/peopleimages.com - stock.adobe.com
Woman talking with doctor via laptop | Image Credit: © Andrey Popov - stock.adobe.com
Stethoscope and doctor sitting with laptop stress headache about work in hospital | Image Credit: ©  joyfotoliakid - stock.adobe.com
Kara L. Watts, MD, answers a question during a Zoom video interview
Colin P. West, MD, PhD, answers a question during a Zoom video interview
Lisa J. Finkelstein, DO, FACOS, answers a question during a Zoom video interview
Doctor using smartphone | Image Credit: © Halfpoint - stock.adobe.com
Lisa J. Finkelstein, DO, FACOS, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.